Papers & Contributions

  1. Fayz El-Kenawy, Afaf Abdel-hafez, Mohamed Ghoneam, Hala Abdel-Hafez and Mohamed Atwa. Brothers of Women with Polycystic Ovary Syndrome: A group with high Risk for type 2 Diabetes Mellitus and Cardiovascular Diseases Studied in Egyptian Population; The International Journal of Medicine, 2009 Vol.2 , Issue1.
  2. Ayman Abdel-Ghafar and Afaf Abdel-hafez. Esophageal Dysmotility in Diabetic Patients with Varices; Arab Journal of Gastroenteroloegy 11(2010) : 192-196.
  3. Maha El-Gayar, Manal Ibrahem, Afaf Abdel-hafez, Neven Omran and Eman Aamer. Evaluation of Thyroid Hormone Abnormalities and Thyroid Autoantibodies in Chronic Idiopathic Urticaria and Alopecia Areata Egyptian patients; Asian Journal of Dermatology, 3 (1): 1-12, 2011.
  4. Eman El-Safty, Medhat Sakrana, Afaf Abdel-hafez, Ayman Abdel-Samad, Adel El-Gamal, Mohamed Foda, Maged Zaghlol, Osama Hamza Yaser El-Ghonemy and Mohamed Regal. Assessment of Mitral Valve Area From long axis and Apical 4-Chamber Echocardiographic Views: Correlation with Direct intra – Operative Measurements. Research Journal of Cardiology, 4(1): 1-15,2011.
  5. Waleed El-Dars, Afaf Abdel-hafez, Medhat M. ALy and Wafaa K. Mowafy. Staphylococcal Food Poisoning in Mansoura University Hospitals; Journal of Tropical Medicine, Accepted in 10-6-2010 - Vol.11 No.3 August, 2010.
  6. Afaf Abdel-hafez and Nadya Hasanen. Impact of normoglycemia on mortality in intensive care unit :ِA prospective study from Mansoura Emergency Hospital; European Journal of dentistry and medicine 3 (1): 12-22, 2011.
  7. Salah Aref, Tarek Selem, Nadya El-Menshawy, Lamyaa Ibrahem, Doaa Abdel-Allah, Manal Foda, Nashwa ABu-Samra, Ayman Menesy, Hassan Abdel-Ghafar, Insaf Bassam and Mohamed Abdel-Wahab.Antiplatelet Antibodies Contribute To Thrombocytopenia Associated With Chronic Hepatitis C Virus Infection; Hematology 2009 Vol. 14 No. 5 277-281
  8. Salah Aref, Nadya El-Menshawy, Doaa Abdel-Allah, Manal Foda, Ayman Menesy, Insaf Bassam, Emad Azmy and Mohamed EL-Refaee. Neutrophil Apoptosis in Neutropenic Patients With Hepatitis C Infection: Role of Caspases 3, 10 and GM-CSF; Indian Journal of Hematology and Blood Transfusion (7 June 2011), pp. 1-7.
  9. Sabry A, Hassan R, Mahmoud I, Hamed M, Sobh M. Proteinuria after kidney transplantation: its relation to hepatitis C virus and graft outcome.. Iran J Kidney Dis. 2007 Oct;1(2):88-97.
  10. Shiha.G, Samir.W, Zalata.K, Zaki.M, Elbeeh.A, Attalah,A. Performance of European Liver Fibrosis (ELF) Markers in Patients with Chronic Hepatitis C Genotype 4. Hepatology International. Feb 2009. (Abstract).
  11. Shiha.G, Samir.W, Zalata.K, Zaki.M, Elbeeh.A, Attalah,A. Performance of fibro-test in patients with chronic hepatitis C genotype 4. Hepatology International. Feb 2009. (Abstract)
  12. Gamal shiha. Editorial. Serum hyaluronic acid: A promising marker of hepatic fibrosis in chronic hepatitis B. The Saudi Journal of gastroentrology. Vol 14 No. 4 October 2008. 
  13. Shiha G, Elshenawy.H, Samir.W., et al. The need for liver biopsy is decreased using a simple score (Fibrofast) of hepatic fibrosis in patients with chronic hepatitis C (poster) 43rd Annual meeting of the European Association for the study of the liver. Italy, Milan, April 2008.
  14. Shiha G, Carvalho Filho R, SebastianiG., et al. Multicentre Validation of A Simple Score For Prediction of Sever Hepatic Fibrosis.Hepatology International. March, 2007. 
  15. Shiha G, Abdelkhalek E, Farouk D. et al. Virological Response of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C Genotype 4. Hepatology International. March, 2007.
  16. Attallah AM, Toson E., Shiha G.,et al. Evaluation of serum procollagen Aminoterminal Propeptide III, Lamimin, and Hydrroxyproline as predictors of Severe Fibrosis in patients with Chronic Hepatitis C. Journal of Immunoassy and Immunochemistry, 28: 199-211,2007.
  17. Attallah AM, Zahran F., Shiha G.,et al. Immunochemical identification and detection of serum fibronectin in liver fibrosis patients with chronic Hepatitis C. Journal of Immunoassay and Immunochemistry, 28: 331-342, 2007.
  18. Attallah AM, Ismail H.,  Shiha GE., et al.   Immunochemical Identification and partial characterization of a native hepatitis C viral non- structural 4 antigen in sera of HCV infected patients.  Clinical Chemica Acta.2007.
  19. Shiha G., Samir W., Zalata K., et al.,  Characterization of identically detected asymptomatic hepattis B positive subjects in Egypt. Arab Journal astroentrology 2007; 8(3): 74-79. 
  20. Attallah AM, Shiha GE, Omran MM, Zalata KR. A discriminant score based on four routine laboratory blood tests for accurate diagnosis of severe fibrosis and/or liver cirrhosis in Egyptian patients with chronic hepatitis C. Hepatology Research. 2006 Feb 11.
  21. Shiha G, Seham S, Zalata K. Hepatic steatosis in chronic hepatitis C virus infection genotype 4: prevalence and clinical correlations. Liver International. (26) 80, September 2006.
  22. Shiha G, Abass A, Elshinawy H, and Zalata K.Sustained virological response of peg-interferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. Liver International. (26) 81, September 2006.
  23. Shiha G, Elshinawy H, Zalata K., et al. Peg-interferon alfa-2b plus riavirin for the treatof chronic hepatitis C genotype 4. Liver International. (26) 79, September 2006.
  24. Abdelfattah MH, Rashed MA, Shiha G., et al. Endoscopic variceal ligation versus pharmacologic treatment for primary prophlaxis of variceal bleeding: a randomized study. Hepatology International. (44) 83, April 2006.
  25. Shiha G, Samir W, Zalata K.Charecterization of patients of coinfected by hepatitis B and hepatitis C viruses. Hepatology International. (44) 176, April 2006.
  26. Attallah A., Toson E., Shiha G., et al. Discriminant function based on Hyaluronic acid and its degrading enzymes and degradation products for differentiating cirrhosis from non-cirrhotic liver diseased patients in chronic HCV infection. Clinical Chemica Acta, 2006.
  27. Shiha G., Khaled RZ., Abdullah AF., Mohamed MK.  Immunohistochemical identification of HCV target antigen in paraffin-embedded liver tissue: reproducibility and staining pattern. Liver International(25) 1 – 7, 2005.
  28. Mohamed. I., Elhabashi. A., Elsawy. E., Elhusseini. A., Shiha. G, et al. The Impact of Hepatitis C virus Viremia on renal graft and patient survival: A 9 – year prospective study. American Journal of kidney diseases, vol 43, No 1, 2004: pp 131 – 139.
  29. Shiha G., AbdAllah.A, Camelia A, Abdel Malak, Nabih A, Elghawalby, Ahmed S Shehatta, Mohamed Abdel-Raouf . Identification of a specific Marker for hepatitis C virus infection using capillary Zone electrophoresis. Clinical chemica  Acta (236) 171-179, 2004.
  30. Shiha G., Zalta. K, Abd-Allah.A, Mohamed.M. Utility of a novel HCV-NS4 antigen detection immunoassay for monitoring treatment of HCV- infected individuals with pegylated interferon α-2a. Hepatology Research, 28, 68-78, 2004.
  31. Shiha. G., Attalah. A. ,  Ismael. H ,  Tabel. A., Eldesouky I. A Novel Antigen Detection Immunoassay for field Diagnosis of Hepatitis C virus infection. Journal of Immunoassay & immunochemistryVol.24. No.4 PP.395-407, 2003.
  32. Shiha G., Zalata. Kh. et al.,Does Schistosomasis interfere with application of knodell score for assessment of chronic hepatitis-C, Medical Science Monitor, 8 (2) 72-77, 2002.
  33. Shiha. G., Salem. S. et al., Gastric variceal ligation:A new technique, Gastrointestinal Endoscopy, volume 49, No.4, part 1, 1999.
  34. Salem. S., G. Shiha, M. Hamed, F. Mohamed, F. Azam. Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices:a randomized study. Gut, 38: 770-7741996.
  35. Ata. A., G. Shiha, S El-Morsy G El-Abady. Detection of schistosoma circulating antigen before and after praziquantel chemotherapy using fast dot ELISA; Journal of Hepatology, Gastroenterology and Infectious Diseases, 4:35-43, 1995.
  36. G. Shiha, M. Hamed, S. Salem, F. Mohamed, H. Askalany. Octerotide infusion plus emergency sclerotherapy versus sclerotherapy alone for the control of bleeding oesophageal varices: A prospective randomized clinical